Dolinsek, T.; Sersa, G.; Prosen, L.; Bosnjak, M.; Stimac, M.; Razborsek, U.; Cemazar, M.
Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects. Cancers 2016, 8, 3.
https://doi.org/10.3390/cancers8010003
AMA Style
Dolinsek T, Sersa G, Prosen L, Bosnjak M, Stimac M, Razborsek U, Cemazar M.
Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects. Cancers. 2016; 8(1):3.
https://doi.org/10.3390/cancers8010003
Chicago/Turabian Style
Dolinsek, Tanja, Gregor Sersa, Lara Prosen, Masa Bosnjak, Monika Stimac, Urska Razborsek, and Maja Cemazar.
2016. "Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects" Cancers 8, no. 1: 3.
https://doi.org/10.3390/cancers8010003
APA Style
Dolinsek, T., Sersa, G., Prosen, L., Bosnjak, M., Stimac, M., Razborsek, U., & Cemazar, M.
(2016). Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects. Cancers, 8(1), 3.
https://doi.org/10.3390/cancers8010003
